Millennium Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,089
Closed -$12K 6796
2024
Q1
$12K Sell
1,089
-1,488
-58% -$16.1K ﹤0.01% 5898
2023
Q4
$34.8K Buy
2,577
+1,242
+93% +$20.1K ﹤0.01% 5535
2023
Q3
$29K Buy
1,335
+87
+7% +$2.79K ﹤0.01% 5579
2023
Q2
$48K Sell
1,248
-8
-0.6% -$282 ﹤0.01% 5481
2023
Q1
$35K Sell
1,256
-6,162
-83% -$209K ﹤0.01% 5735
2022
Q4
$244K Buy
7,418
+3,696
+99% +$270K ﹤0.01% 5217
2022
Q3
$451K Sell
3,722
-1,340
-26% -$241K ﹤0.01% 5048
2022
Q2
$886K Sell
5,062
-3,065
-38% -$646K ﹤0.01% 4483
2022
Q1
$2.36M Buy
8,127
+6,321
+350% +$2.4M ﹤0.01% 3717
2021
Q4
$944K Buy
1,806
+1,691
+1,470% +$1.21M ﹤0.01% 4460
2021
Q3
$44K Sell
115
-390
-77% -$167K ﹤0.01% 6598
2021
Q2
$451K Buy
505
+306
+154% +$234K ﹤0.01% 5394
2021
Q1
$237K Sell
199
-133
-40% -$183K ﹤0.01% 5398
2020
Q4
$441K Sell
332
-142
-30% -$208K ﹤0.01% 4292
2020
Q3
$1.07K Buy
474
+1
+0.2% +$2.26K ﹤0.01% 3087
2020
Q2
$1.06M Buy
+473
New +$1.29M ﹤0.01% 2953

Other funds holding BIOR

Millennium Management's BIOR Position: Q2 2024 in Review

Millennium Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2024, closing a stake of 1,089 shares — an estimated $12K sold.

Millennium Management first reported a position in BIOR in Q2 2020 and held it in 16 quarters. The position peaked at $2.36M in Q1 2022. 26 funds tracked by Wall St. Rank hold BIOR as of Q2 2024.

  • Millennium Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 1,089 Biora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $12K.
  • Millennium Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Millennium Management's Biora Therapeutics, Inc. Common Stock position peaked at $2.36M in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.